BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32818716)

  • 1. Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
    Jarvis KB; Nielsen RL; Gupta R; Hede FD; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Saks K; Trakymiene SS; Tuckuviene R; Tulstrup M; ; Ruud E; Schmiegelow K; LeBlanc M
    Thromb Res; 2020 Dec; 196():15-20. PubMed ID: 32818716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
    Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
    Thromb Res; 2019 Dec; 184():92-98. PubMed ID: 31715544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
    Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
    J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
    Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
    Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
    Athale UH; Flamand Y; Blonquist T; Stevenson KE; Spira M; Asselin BL; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29581. PubMed ID: 35316569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiancestral polygenic risk score for pediatric asthma.
    Namjou B; Lape M; Malolepsza E; DeVore SB; Weirauch MT; Dikilitas O; Jarvik GP; Kiryluk K; Kullo IJ; Liu C; Luo Y; Satterfield BA; Smoller JW; Walunas TL; Connolly J; Sleiman P; Mersha TB; Mentch FD; Hakonarson H; Prows CA; Biagini JM; Khurana Hershey GK; Martin LJ; Kottyan L;
    J Allergy Clin Immunol; 2022 Nov; 150(5):1086-1096. PubMed ID: 35595084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating genomic polygenic risk scores for childhood acute lymphoblastic leukemia in Latinos.
    Jeon S; Lo YC; Morimoto LM; Metayer C; Ma X; Wiemels JL; de Smith AJ; Chiang CWK
    HGG Adv; 2023 Oct; 4(4):100239. PubMed ID: 37710962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and optimization of a polygenic risk model for venous thromboembolism in the Chinese population.
    Liu C; Hou J; Li W; Chen J; Li Y; Zhang J; Zhou W; Zhang W; Deng F; Wang Y; Chen L; Qin S; Meng X; Lu S
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101666. PubMed ID: 37619711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
    Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK
    BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Implementation of Penalized Regression for Genetic Risk Prediction.
    Privé F; Aschard H; Blum MGB
    Genetics; 2019 May; 212(1):65-74. PubMed ID: 30808621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On polygenic risk scores for complex traits prediction.
    Zhao B; Zou F
    Biometrics; 2022 Jun; 78(2):499-511. PubMed ID: 33786811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging Genome and Phenome-Wide Association Studies to Investigate Genetic Risk of Acute Lymphoblastic Leukemia.
    Semmes EC; Vijayakrishnan J; Zhang C; Hurst JH; Houlston RS; Walsh KM
    Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1606-1614. PubMed ID: 32467347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Polygenic Risk Score Suggests Shared Genetic Architecture of Voice Break With Early Markers of Pubertal Onset in Boys.
    Lardone MC; Busch AS; Santos JL; Miranda P; Eyheramendy S; Pereira A; Juul A; Almstrup K; Mericq V
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31915828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging both individual-level genetic data and GWAS summary statistics increases polygenic prediction.
    Albiñana C; Grove J; McGrath JJ; Agerbo E; Wray NR; Bulik CM; Nordentoft M; Hougaard DM; Werge T; Børglum AD; Mortensen PB; Privé F; Vilhjálmsson BJ
    Am J Hum Genet; 2021 Jun; 108(6):1001-1011. PubMed ID: 33964208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.
    Rank CU; Wolthers BO; Grell K; Albertsen BK; Frandsen TL; Overgaard UM; Toft N; Nielsen OJ; Wehner PS; Harila-Saari A; Heyman MM; Malmros J; Abrahamsson J; Norén-Nyström U; Tomaszewska-Toporska B; Lund B; Jarvis KB; Quist-Paulsen P; Vaitkevičienė GE; Griškevičius L; Taskinen M; Wartiovaara-Kautto U; Lepik K; Punab M; Jónsson ÓG; Schmiegelow K
    J Clin Oncol; 2020 Jan; 38(2):145-154. PubMed ID: 31770057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and validation of genome-wide polygenic score for urinary tract stone diagnosis.
    Paranjpe I; Tsao N; Judy R; Paranjpe M; Chaudhary K; Klarin D; Forrest I; O'Hagan R; Kapoor A; Pfail J; Jaladanki S; Chaudhry F; Vaid A; Duy PQ; ; ; He JC; Glicksberg BS; Coca SG; Gupta M; Do R; Damrauer SM; Nadkarni GN
    Kidney Int; 2020 Nov; 98(5):1323-1330. PubMed ID: 32540406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
    Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
    Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A statistical genetic investigation of psychiatric resilience.
    Cusack SE; Aliev F; Bustamante D; ; Dick DM; Amstadter AB
    Eur J Psychotraumatol; 2023; 14(1):2178762. PubMed ID: 37052082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
    Roberts MR; Asgari MM; Toland AE
    Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
    Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.